SCPH insider converts options to cash plus CVRs in $5.35 deal
Rhea-AI Filing Summary
Director Jack A. Khattar reported changes in his holdings following a completed merger transaction. He disposed of 5,000 shares of common stock on 10/07/2025, leaving him with 0 shares of direct common stock. The transactions occurred under a Merger Agreement in which purchasers paid $5.35 per share in cash in a tender offer and issued one non-tradable contingent value right (CVR) per share that may pay up to $1.00 aggregate upon achievement of specified regulatory and net sales milestones. Outstanding company stock options with exercise prices below $5.35 were cancelled and converted into cash payments equal to the excess of $5.35 over the option exercise price, plus one CVR per underlying share; several option grants totaling 72,174 options (aggregate of listed amounts) were reported as disposed/converted.
Positive
- Director received cash consideration of $5.35 per share for tendered shares
- Each tendered share and each converted option also received one CVR providing up to $1.00 potential additional cash per CVR
Negative
- Reporting person holds 0 direct common shares after the reported sale
- Outstanding options with exercise prices below $5.35 were cancelled, eliminating future direct equity upside
Insights
Insider holdings moved to cash and CVRs as part of a $5.35-per-share transaction.
The director sold 5,000 shares and reported 0 remaining direct shares after a tender offer that paid $5.35 per share plus one CVR per share. Unexercised options with exercise prices below $5.35 were cancelled and converted into cash equal to the spread and one CVR per underlying share.
Key dependencies are the CVR milestone outcomes and timing for any contingent payments; investors should note CVRs are non-tradable and pay only if regulatory and net sales triggers occur within stated milestone windows.
Option cancellation converted equity compensation into immediate cash value plus contingent upside.
Several stock option grants were listed as cancelled/converted on 10/07/2025 with exercise prices below the transaction price; each was converted into a cash payment equal to ($5.35 minus exercise price) times shares, plus one CVR per share. The filing lists four option groups totaling 72,174 options affected by the conversion.
This treatment removes future equity upside for the holder and replaces it with fixed cash consideration plus contingent CVR exposure; the value realization depends on milestone attainment on or before the applicable milestone-outside dates.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock Option (Right to Buy) | 30,000 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 19,750 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 16,300 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 6,124 | $0.00 | -- |
| U | Common Stock | 5,000 | $0.00 | -- |
Footnotes (1)
- In connection with the terms of an Agreement and Plan of Merger, dated as of August 24, 2025 (the "Merger Agreement"), by and among the Issuer, MannKind Corporation ("Parent") and Seacoast Merger Sub, Inc., a direct wholly owned subsidiary of Parent ("Purchaser"), Purchaser completed a tender offer for shares of the Issuer's common stock ("Common Stock") on October 7, 2025. Tendering stockholders received per share consideration of $5.35 in cash, without interest, subject to any applicable withholding taxes, plus one non-tradable contingent value right ("CVR"), representing the right to receive certain contingent payments of up to an aggregate amount of $1.00 per CVR in cash, (Continued from footnote 1) without interest, subject to any applicable withholding taxes, upon the achievement of certain regulatory and net sales milestones on or prior to the applicable milestone outside dates. After completion of the tender offer, Purchaser merged with and into the Issuer (the "Merger", and the effective time of the Merger, the "Effective Time"), with the Issuer continuing as the surviving corporation in the Merger and a wholly owned subsidiary of Parent. Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each option to purchase shares of Common Stock (a "Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time and that had an exercise price per share that was less than $5.35, whether or not then vested or exercisable, was cancelled and converted into the right to receive (i) an amount in cash, without interest and subject to any applicable withholding taxes, equal to (A) the total number of shares subject to such Company Option immediately prior to such cancellation multiplied by (B) the excess, if any, of (x) $5.35 over (y) the exercise price payable per share underlying such Company Option and (ii) one CVR in respect of each share subject to such Company Option.
